ArticleNIHR open research2026
Understanding possible differences between haemodialysis and haemodiafiltration which affect survival in end-stage kidney disease dialysis patients: the STITCHED study halted by the COVID-19 epidemic.
Article in NIHR open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The mortality rate of kidney dialysis patients remains high, predominantly due to cardiovascular disease. The clearance of uraemic solutes with standard high-flux haemodialysis (HD) is mainly mediated by diffusion. More recently, haemodiafiltration (HDF), which adds convection, thus increasing the spectrum of cleared uraemic toxins, has been introduced into clinical practice. Recent reports have suggested that HDF treatment improves patient outcomes. However, it is unclear as to the amount of HDF treatment required or why HDF should improve patient outcomes.The UK High-Volume Haemodiafiltration vs. High-Flux Haemodialysis Registry Trial (H4RT) study compared a composite of non-cancer mortality or hospital admission with a cardiovascular event or infection over 3 years. However, this study was not designed to investigate why HDF may have improved patient outcomes; therefore, the STITCHED study (Study To Investigate The Change in Hypotensive Episodes during Dialysis) was designed to be nested within the larger H4RT study. Objective: The STITCHED study was designed to investigate the potential mechanisms underlying the improved survival reported with HDF. Design and methods: The STITCHED study was designed to investigate changes in intra- and inter-dialytic blood pressure; differences in the clearance of uraemic toxins, temperature, sodium, and calcium balance between HDF and HD treatments; and the effects on the heart and brain by measuring differences in arterial stiffness, cardiac dimensions, and cognitive function. Setting and participants: Nine acute hospital trusts across England were contacted and involved in the STITCHED study. However, after delays due to covid-19 only the Royal Free Hospital in London recruited participants. Results: After disruptions due to the covid-19 pandemic the study was stopped before any results were obtained. Conclusion: The STITCHED study was halted before any relevant information was obtained, and as such was unable to answer the question of why one mode of dialysis should improve patient survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.